Establishment and characterization of cell lines from chromosomal instable colorectal cancer

Table 2 Flow cytometric phenotyping of colorectal carcinoma cell lines and major histocompatibility complex expression with and without interferon-γ pre-treatment

Antigen	HROC18P	HROC32P
CD58	3.6%	16.4%
CD71	38.5%	39.4%
CD50	15.1%	20.3%
CD54	8.9%	27.0%
CD102	22.4%	11.8%
CD326	88.1%	83.0%
CD24	9.5%	0.6%
CD44	52.3%	41.4%
CD66acde	3.3%	13.3%
CD15	75.1%	46.7%
CD55	1.0%	6.8%
HLA-A2	98.6%	96.5%
MHC class I
- IFN-γ	99.0%	99.0%
+ IFN-γ	99.0%	99.0%
MHC class II
- IFN-γ	0.0%	2.5%
+ IFN-γ	77.0%	80.0%

Data are given from one representative experiment. CD: Cluster of differentiation; IFN: Interferon; HLA: Human leukocyte antigen; MHC: Major histocompatibility complex.